The role of WNT10B in physiology and disease
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Wnt10b is a member of the Wnt ligand gene family that encodes for secreted proteins, which activate the ancient and highly conserved Wnt signalling cascade. The Wnt pathway has been shown to be essential for embryonic development, tissue integrity, and stem cell activity, but if deregulated, also causes disease such as cancer. Although the 19 different Wnt ligands found in both human and mouse can activate several branches of the Wnt pathway, WNT10B specifically activates canonical Wnt/β‐catenin signalling and thus triggers β‐catenin/LEF/TCF‐mediated transcriptional programs. In this review, we highlight the unique functions of WNT10B and mechanisms of how WNT10B acts in the immune system, mammary gland, adipose tissue, bone and skin. In these organs, WNT10B has been well established to be involved in signalling networks controlling stemness, pluripotency and cell fate decisions. Deregulation of these processes causes diseases such as breast cancer, obesity and osteoporosis. Compelling evidence suggests that WNT10B is a valuable candidate for the development of therapeutic regimens for human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602 · cited 1×
“Intermitted treatment with fragment 1–34 of parathyroid hormone (iPTH) has been shown to improve bone architecture and strength and was thus approved for osteoporosis treatment (Neer et al. 2001).”
BackgroundFunctional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912 · cited 1×
“The functional interaction between b-catenin and LEF-1 was nicely demonstrated by the Birchmeier laboratory in 1996 and is evolutionary conserved amongst various species (Behrens et al. 1996).”
BackgroundAdipocyte differentiation from the inside out
Rosen, E. D., & MacDougald, O. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2066 · Cited by 2,607
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
Generation of a functional mammary gland from a single stem cell
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M.-L., Wu, L., Lindeman, G. J., & Visvader, J. E. (2006) · Nature · doi:10.1038/nature04372 · Cited by 2,005 · cited 1×
“In addition, the Visvader group showed an increase in the number of MaSCs in mammary glands of MMTV-Wnt1 transgenic mice and demonstrated that MaSCs are indeed triple-negative (Shackleton et al. 2006, Visvader 2009).”
BackgroundXTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779 · cited 1×
“Therapeutic strategies for osteoporosis treatment mainly focus on resorption inhibitors (Raisz 2005).”
BackgroundWNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763 · cited 1×
“Consequently stabilization of b-catenin levels leads to translocation to the nucleus where it will function as co-activator of transcription (Moon et al. 2004).”
BackgroundDickkopf-1 is a member of a new family of secreted proteins and functions in head induction
Glinka, A., Wu, W., Delius, H., Monaghan, A. P., Blumenstock, C., & Niehrs, C. (1998) · Nature · doi:10.1038/34848 · Cited by 1,608 · cited 1×
“…receptor Frizzled (Fzd) family members and co-receptors Arrow/Low Density Lipoproteins 5/6 (LRP5/6) affect the downstream regulator Armadillo/b-catenin (DeMarais & Moon 1992, Yang-Snyder et al. 1996, Leyns et al. 1997, Glinka et al. 1998, Tamai et al. 2000, Wehrli et al. 2000, Gong et al. 2001).”
BackgroundHigh Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591 · cited 1×
“In contrast, an activating mutation in LRP5 has been shown to result in high bone mass (Boyden et al. 2002, Little et al. 2002).”
BackgroundMinireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515 · cited 1×
“…Runx2 and Osterix, whereas osteoclast differentiation is controlled by two important cytokines, macrophage colonystimulating factor (M-CSF) and receptor-activator of nuclear factor-jB ligand (RANKL) that are secreted by osteoblasts, stromal cells and T cells (Suda et al. 1999, Khosla 2001).”
BackgroundRegulation of bone mass by Wnt signaling
Krishnan, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28551 · Cited by 1,407 · cited 1×
“In addition, a broad variety of other mouse models was established to study the function of Wnt/b-catenin signalling in bone (reviewed in Krishnan et al. 2006, Glass & Karsenty 2007, Grigoryan et al. 2008).”
BackgroundLittle, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
WNT Signals Are Required for the Initiation of Hair Follicle Development
Andl, T., Reddy, S. T., Gaddapara, T., & Millar, S. E. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00167-3 · Cited by 1,088
Kato, M., Patel, M. S., Levasseur, R., Lobov, I., Chang, B. H.-J., Glass, D. A., Hartmann, C., Li, L., Hwang, T.-H., Brayton, C. F., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200201089 · Cited by 1,086 · cited 3×
“One important breakthrough studying the role of Wnt signalling in osteoblastogenesis was the observation that LRP5-knockout mice have a strongly reduced bone mass (Kato et al. 2002) and vice versa, gain-of-function mutations in LRP5 cause higher bone density in mice (Babij et al. 2003).”
BackgroundNovel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow
Bafico, A., Liu, G., Yaniv, A., Gazit, A., & Aaronson, S. A. (2001) · Nature Cell Biology · doi:10.1038/35083081 · Cited by 772
Brunner, E., Peter, O., Schweizer, L., & Basler, K. (1997) · Nature · doi:10.1038/385829a0 · Cited by 493
Reddy, S., Andl, T., Bagasra, A., Lu, M. M., Epstein, D. J., Morrisey, E. E., & Millar, S. E. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00452-x · Cited by 489 · cited 1×
“Importantly, the earliest and highest expressed Wnt ligand in hair follicle development and hair cycle induction was shown to be Wnt10b (Reddy et al. 2001).”
BackgroundNiehrs, C. (2010) · Development · doi:10.1242/dev.039651 · Cited by 283 · cited 1×
“Recent insights into evolutionary developmental biology have provided us with clues that Wnt signalling has been conserved as far back as Cnidarians (e.g. Hydra) or predating the Cnidarians’ bilateral split (Holstein 2008, Niehrs 2010).”
BackgroundCanonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
Yuzugullu, H., Benhaj, K., Ozturk, N., Senturk, S., Celik, E., Toylu, A., Tasdemir, N., Yilmaz, M., Erdal, E., Akcali, K. C., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-90 · Cited by 215 · cited 1×
“…WNT2B, 5A, 10B, 16B Khan et al. 2007 Liver cancer WNT1, 2, 2B, 3, 3A, 4, 5A, 5B, 6, 7A, 7B, 8A, 8B, 9A, 9B, 10A, 10B, 11, 16 Yoshikawa et al. 2007, Yuzugullu et al. 2009 Osteosarcoma WNT2B, 3, 4, 5A, 5B, 7A, 10B, 14 Iozzo et al. 1995, Hoang et al. 2004, Chen et al. 2008 Ovarian cancer WNT9B, 10B…”
Wei, J., Melichian, D., Komura, K., Hinchcliff, M., Lam, A. P., Lafyatis, R., Gottardi, C. J., MacDougald, O. A., & Varga, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30312 · Cited by 214
Wnt10b Deficiency Promotes Coexpression of Myogenic and Adipogenic Programs in Myoblasts
Vertino, A. M., Taylor-Jones, J. M., Longo, K. A., Bearden, E. D., Lane, T. F., McGehee, R. E., MacDougald, O. A., & Peterson, C. A. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0720 · Cited by 158 · cited 3×
“…increase in mammary stem cells Lane & Leder 1997, Miranda-Carboni et al. 2008 Muscle Myoblast Wnt10b)/) LOF Induction of an adipogenic cell fate Vertino et al. 2005 Tongue Fungiform papilla Wnt10b)/) LOF Reduced size and numbers of fungiform papillae Iwatsuki et al. 2007 *Tissues and…”
BackgroundInfluentialWnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival
Chen, K., Fallen, S., Abaan, H. Ö., Hayran, M., Gonzalez, C., Wodajo, F., MacDonald, T., Toretsky, J. A., & Üren, A. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21595 · Cited by 74 · cited 3×
“…9B, 10A, 10B, 11, 16 Yoshikawa et al. 2007, Yuzugullu et al. 2009 Osteosarcoma WNT2B, 3, 4, 5A, 5B, 7A, 10B, 14 Iozzo et al. 1995, Hoang et al. 2004, Chen et al. 2008 Ovarian cancer WNT9B, 10B Steg et al. 2006 Pancreatic cancer WNT7A, 10B, 14 Kirikoshi et al. 2001b, Kirikoshi & Katoh…”
BackgroundInfluential
Cited by
Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Song, P., Gao, Z., Bao, Y., Chen, L., Huang, Y., Liu, Y., Dong, Q., & Wei, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01563-4 · Cited by 382
“Wnt10b plays a pivotal role in regulating the signaling network governing stemness, pluripotency, and cell fate in various organs [49].”
BackgroundVlashi, R., Zhang, X., Wu, M., & Chen, G. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.07.011 · Cited by 165
Chen, Z., Chen, L., Liu, R., Lin, Y., Chen, S., Lu, S., Lin, Z., Chen, Z., Wu, C., & Xiao, Y. (2018) · Biomaterials Science · doi:10.1039/c7bm00869d · Cited by 92
Etiology and pathogenesis of ectodermal dysplasias
Itin, P. H. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36550 · Cited by 69
Metadata
- Authors
- Wend, P., Wend, K., Krum, S. A., & Miranda‐Carboni, G. A.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2011-05-07
- Volume
- 204
- Issue
- 1
- Pages
- 34-51
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W1901220202
- Cited by
- 97
- References
- 24
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.